{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:27Z","timestamp":1792834707749,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015075","name":"Kagawa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pdpdt.2026.105659","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:04:28Z","timestamp":1790175868000},"page":"105659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Photoimmunotherapy for recurrent or unresectable head and neck cancer: Clinical outcomes and perioperative airway management"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5111-3142","authenticated-orcid":false,"given":"Takehito","family":"Kishino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-5620","authenticated-orcid":false,"given":"Takenori","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Samukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuki","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyuki","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kokushi","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2026.105659_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0002","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"KEYNOTE-048 investigators, Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.pdpdt.2026.105659_bib0003","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0004","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/hed.26885","article-title":"Phase 1\/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma","volume":"43","author":"Cognetti","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.pdpdt.2026.105659_bib0005","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/cancers17162671","article-title":"Real-world effectiveness and safety of photoimmunotherapy for head and neck cancer: a multicenter retrospective study","volume":"17","author":"Okamoto","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pdpdt.2026.105659_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2026.105360","article-title":"Real-world outcomes of photoimmunotherapy for oral sites in head and neck cancer: a multicentre subgroup analysis","volume":"58","author":"Hasegawa","year":"2026","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0007","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.3390\/cancers15153795","article-title":"Eligibility for photoimmunotherapy in patients with unresectable advanced or recurrent head and neck cancer and changes before and after systemic therapy","volume":"15","author":"Shinozaki","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pdpdt.2026.105659_bib0008","doi-asserted-by":"crossref","first-page":"179","DOI":"10.21873\/cdp.10428","article-title":"Predictive factors for the efficacy of head and neck photoimmunotherapy and optimization of treatment schedules","volume":"5","author":"Nishikawa","year":"2025","journal-title":"Cancer Diagn. Progn."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0009","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nm.4466","article-title":"High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy","volume":"24","author":"Krieg","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0011","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0012","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0013","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2326-6066.CIR-18-0546","article-title":"Host immunity following near-infrared photoimmunotherapy is enhanced with PD-1 checkpoint blockade to eradicate established antigenic tumors","volume":"7","author":"Nagaya","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.pdpdt.2026.105659_bib0014","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hed.70014","article-title":"Safety and efficacy findings from a phase Ib\/II study of ASP-1929 photoimmunotherapy with pembrolizumab in recurrent and\/or metastatic head and neck squamous cell carcinoma","volume":"48","author":"Cognetti","year":"2026","journal-title":"Head Neck"},{"key":"10.1016\/j.pdpdt.2026.105659_bib0015","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJMra1209390","article-title":"ICU-acquired weakness and recovery from critical illness","volume":"370","author":"Kress","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026003261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026003261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:57:15Z","timestamp":1792832235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100026003261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":15,"alternative-id":["S1572100026003261"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105659","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photoimmunotherapy for recurrent or unresectable head and neck cancer: Clinical outcomes and perioperative airway management","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105659"}}